Related Experiment Video

Updated: Jan 18, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

37.7K

Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026

Allan De Clercq1,2, François Blanquart3, Vincent Vieillefond4

  • 1Hospices Civils de Lyon (HCL), Centre National de Référence des virus des infections respiratoires, Institut des Agents Infectieux, Laboratoire de Virologie, Lyon, France.

Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|January 16, 2026
PubMed

Keywords:
Influenzaacute respiratory infectionsurveillancevaccine effectiveness

More Related Videos

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

26.0K
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis09:02

Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis

Published on: February 20, 2021

3.4K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
51.3K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908